Gustave Ronteix

Founder

Life sciences

Now Founder · Orakl Oncology

orakl-oncology.com

Latest on AI4S.fyi

FUNDING · 2026-11-13

Orakl Oncology · Series A · $34M

Path

OO
Orakl Oncology2023 – presentFounder

Founded

Orakl OncologyDrug discovery · 2023 · 3 rounds on record · disclosed $34M + €14M · Series A $34M
Background: Gustave Roussy spin-out team; CTO (as the company's own announcements put it)
Co-founders: Fanny Jaulin, Diane-Laure Pagès
Backed byNorrsken VC Singular Speedinvest

On the timeline

2026-11-13Gustave Roussy spin-out Orakl Oncology raises a $34M Series A, co-led by Norrsken VC and Singular, to predict cancer-drug trials from patients' tumour organoids

Sourcesmcdermottlaw.com

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →